Pure Global AI
ANVISA registration 10345162561Valid until May 04, 2036

PROSTATE-SPECIFIC ANTIGEN (PSA)

ANVISA Registration Number: 10345162561SIEMENS HEALTHCARE DIAGNÓSTICOS LTDASIEMENS HEALTHCARE DIAGNOSTICS INC.Risk Class III
Verified
Device names
Technical name
PROSTATE-SPECIFIC ANTIGEN (PSA)
View exact technical-name matches →
PT: ANTÍGENO PROSTÁTICO ESPECÍFICO (PSA)
Commercial name
Atellica IM PSA de Alta Sensibilidade (hsPSA)
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10345162561
Process Number
25351018603202656
CNPJ
01449930000190
Company information
Registration Holder
SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
May 04, 2026
Validity
04/05/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for PROSTATE-SPECIFIC ANTIGEN (PSA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10345162561 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until May 04, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.